HBC August 2020 News Bulletin

Monday, August 31, 2020

 

HBC New Research Assistant Professor

Lan GuoDr. Lan Guo recently joined HBC as a research assistant professor.  Focusing on deciphering the pathogenesis of Alzheimer’s disease, Dr. Guo is trying to probe the role of neuronal-microglial crosstalk in the development of neurodegeneration in this devastating disorder by adopting multidisciplinary approaches including molecular neurobiology, live cell imaging and transcriptomics. The understanding of key mechanisms of such complicated inter-cell type communication holds hope for the development of therapeutic avenues for the treatment of Alzheimer’s disease.

 

HBC New Internal Advisory Committee Member

Anthony Fehr We would like to welcome the latest member of the HBC Internal Advisory Committee, Anthony Fehr, assistant professor of molecular biosciences.  The HBC advisory committee, chaired by John Stobaugh, interim director of HBC, has eight members that represent several HBC participants’ departments.

 

Upcoming Fall Symposium

GRASP Logo An HBC sponsored symposium is scheduled for this coming fall.   The 2020 Great Plains Regional Annual Symposium on Protein and Biomolecular NMR (GRASP NMR), a regional symposium on macromolecular NMR applications and techniques, will be held virtually, via zoom, October 9 - 10, 2020.  Registration is currently open.  To be considered for an oral presentation, please submit your abstract to Roberto De Guzman  by Thursday, Sep 17, 2020.  

 

Higuchi Biosciences Center Hosting Seminar

Please, save the date!  The Higuchi Biosciences Center will be hosting a virtual seminar, via zoom, on October 2, 2020, at 9:00 am. The invited speaker is  Dr. Angela KoehlerAngela Koehler, associate professor of biological engineering at MIT.  Dr Koehler is an institute fellow in the Chemical Biology Program at the Broad Institute of MIT and Harvard.  She is also a group leader for the NCI Initiative for Chemical Genetics and a project leader in the NCI Cancer Target Discovery and Development (CTD2) Center at the Broad Institute.  Her research focuses on building chemical tools and methods for studying temporal aspects of transcriptional regulation in development and disease with a focus on cancer.  More information about the seminar will be sent in September.

 

NIH & NSF Updates

  • Save the dates!  The NIH will hold a Fall 2020 Virtual Regional Seminar on Program Funding and Grants Administration from Tuesday, October 27, to Friday, October 30,  2020.  Registration will open September 4 and will be free. 
  • The COVID-19: Information for NIH Applicants and Recipients of NIH Funding webpage is continuously being updated by NIH and now offers more information on COVID-19 related topics such as guidance for award applications for the Fall 2020, funding opportunities specific to COVID-19, description of the peer review process, etc.  Take the time to visit the page to read the latest COVID-19 related information.
  • Starting on October 1, 2020, award recipients will notice a new standardized Page One in NIH Notice of Award (NoA).  The new format will display key award information on the first page as well as a list of the federal agency contacts and other data elements usually found on other pages.  The remaining sections will remain mostly the same.
  • In the April-May News Bulletin, we indicated that the NSF was going to require the use of SciENcv for all biosketches and other supports starting June 1, 2020. The NSF pushed back the required date to October 5, 2020.  A webinar on the use of these new formats as well as webpages and FAQs were made available to assist users. 


Grant Submission Deadlines

March 5, 2021
NIH standard deadline for Research Grants and Cooperative Agreements (R01 and U01) – renewal, resubmission, revision.

March 11, 2021
DoD Breast Cancer Breakthrough Award Levels 1 & 2 & Era of Hope Scholar Award – Pre-application.

March 12, 2021
DoD Breast Cancer Breakthrough Award Levels 3 & 4  & Innovator Award – Pre-application.

March 16, 2021
NIH standard deadline for Other Research Grants and Cooperative Agreements (R03, R21, R33, R21/R33, R34, R36, UH2, UH3, UH2/UH3) – renewal, resubmission, revision.

Recent Awards

Yoshiaki Azuma, Professor, Department of Molecular Biosciences, was awarded $35,000 by the University of Kansas Medical Center Research Institute for his project entitled “Targeting mitotic function of the PICH (Polo-like kinase interacting checkpoint helicase) for novel therapeutics of TNBC.”

Heng Du, Associate Professor, Department of Pharmacology & Toxicology, transferred a grant from  the University of Dallas, Texas.  It is a BrightFocus Foundation project entitled “Synaptic mitochondrial calcium uniporter deregulation and synaptic injury in Alzheimer's disease.”

Teruna Siahaan, Aya and Takeru Higuchi Distinguished Professor and Associate Chair, Department of Pharmaceutical Chemistry, was awarded $25,000 by the PHRMA Foundation as mentor for Kelly Schwinghamer for the project entitled “Non-Invasive Brain Delivery Clearance  and Efficacy of Therapeutic Antibodies in Mice.”

Liang Xu, Professor, Department of Molecular Biosciences, was awarded $35,000 by the University of Kansas Medical Center Research Institute for his project entitled “Drug the Undruggable Musashi Oncoprotein by Fragment-based Drug Discovery.”

One of 34 U.S. public institutions in the prestigious Association of American Universities
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
—ALA
5th nationwide for service to veterans —"Best for Vets: Colleges," Military Times
KU Today